I think I recall a couple of years ago there was a study that was shown, respected, and you probably know it better than I, that $2 million for gene therapy for ultra-rare diseases was a reasonable sort of--it would cover the cost.
Cassidy discusses the cost of gene therapy for ultra-rare diseases.
Share
More from Bill Cassidy
An American business’s tax dollars should not go to a foreign competitor that is trying to undercut the business paying the taxes. If we apply this principle, it will protect the Louisiana shrimping industry, the jobs, and their families.
I guess my point is, though, that the American people need to know more than we’re being told.
If you build public health upon a foundation of lies, then you're going to have the absence of adequate public health.
Other voices in this conversation
